Neuroprotective effects of novel small peptides in vitro and after brain injury

Neuropharmacology

Volumn 49, Issue 3, 2005, Pages 410-424

  Faden, Alan I ^a   Movsesyan, Vilen A ^a   Knoblach, Susan M ^a   Ahmed, Farid ^a   Cernak, Ibolja ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cell death; Cyclic dipeptides; Magnetic resonance imaging; Microarray; Neuroprotection; Traumatic brain injury

Indexed keywords

DIPEPTIDE; PIPERAZINEDIONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; CELL CYCLE; CELL DEATH; COGNITION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; HIPPOCAMPUS; MOTOR PERFORMANCE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

AMYLOID BETA-PROTEIN; ANIMALS; BRAIN INJURIES; CELL SURVIVAL; CELLS, CULTURED; FEMALE; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; L-LACTATE DEHYDROGENASE; MAGNETIC RESONANCE IMAGING; MAZE LEARNING; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEURONS; NEUROPROTECTIVE AGENTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 23444442242     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2005.04.001     Document Type: Article

References (40)

1. J.W. Allen, S. Vicini, and A.I. Faden Exacerbation of neuronal cell death by activation of group I metabotropic glutamate receptors: role of NMDA receptors and arachidonic acid release Exp. Neurol. 169 2001 449 460
2. M.J. Arias Treatment of experimental spinal cord injury with TRH, naloxone, and dexamethasone Surg. Neurol. 28 1987 335 338
3. M. Bakay, Y.W. Chen, R. Borup, P. Zhao, K. Nagaraju, and E.P. Hoffman Sources of variability and effect of experimental approach on expression profiling data interpretation BMC Bioinform. 3 2002 4
4. D.L. Behrmann, J.C. Bresnahan, and M.S. Beattie Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673 Exp. Neurol. 126 1994 61 75
5. M.B. Bracken, and T.R. Holford Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2 J. Neurosurg. 79 1993 500 507
6. A. Buki, O. Farkas, T. Doczi, and J.T. Povlishock Preinjury administration of the calpain inhibitor MDL-28170 attenuates traumatically induced axonal injury J. Neurotrauma 20 2003 261 268
7. S. Di Giovanni, S.M. Knoblach, C. Brandoli, S.A. Aden, E.P. Hoffman, and A.I. Faden Gene profiling in spinal cord injury shows role of cell cycle in neuronal death Ann. Neurol. 53 2003 454 468
8. A.I. Faden Neuroprotection and traumatic brain injury: theoretical option or realistic proposition Curr. Opin. Neurol. 15 2002 707 712
9. A.I. Faden, P. Demediuk, S.S. Panter, and R. Vink The role of excitatory amino acids and NMDA receptors in traumatic brain injury Science 244 1989 798 800
10. A.I. Faden, G.B. Fox, X. Di, S.M. Knoblach, I. Cernak, P. Mullins, M. Nikolaeva, and A.P. Kozikowski Neuroprotective and nootropic actions of a novel cyclized dipeptide after controlled cortical impact injury in mice J. Cereb. Blood Flow Metab. 23 2003 355 363
11. A.I. Faden, G.B. Fox, L. Fan, G.L. Araldi, L. Qiao, S. Wang, and A.P. Kozikowski Novel TRH analog improves motor and cognitive recovery after traumatic brain injury in rodents Am. J. Physiol. 277 1999 R1196 R1204
12. A.I. Faden, S.M. Knoblach, I. Cernak, L. Fan, R. Vink, G.L. Araldi, S.T. Fricke, B.L. Roth, and A.P. Kozikowski Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection in vitro and in vivo J. Cereb. Blood Flow Metab. 23 2003 342 354
13. A.I. Faden, S.M. Knoblach, V.A. Movsesyan, and I. Cernak Novel small peptides with neuroprotective and nootropic properties J. Alzheimer's Dis. 6 2004 S93 S97
14. A.I. Faden, D.M. O'Leary, L. Fan, W. Bao, P.G. Mullins, and V.A. Movsesyan Selective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improves outcome after brain trauma Exp. Neurol. 167 2001 435 444
15. A.I. Faden, R. Vink, and T.K. McIntosh Thyrotropin-releasing hormone and central nervous system trauma Ann. N. Y. Acad. Sci. 553 1989 380 384
16. G.B. Fox, L. Fan, R.A. Levasseur, and A.I. Faden Sustained sensory/motor and cognitive deficits with neuronal apoptosis following controlled cortical impact brain injury in the mouse J. Neurotrauma 15 1998 599 614
17. D.I. Graham, S.M. Gentleman, J.A. Nicoll, M.C. Royston, J.E. McKenzie, G.W. Roberts, R.E. Mrak, and W.S. Griffin Is there a genetic basis for the deposition of beta-amyloid after fatal head injury? Cell. Mol. Neurobiol. 19 1999 19 30
18. R. Gulino, S.A. Lombardo, A. Casabona, G. Leanza, and V. Perciavalle Levels of brain-derived neurotrophic factor and neurotrophin-4 in lumbar motoneurons after low-thoracic spinal cord hemisection Brain Res. 1013 2004 174 181
19. J. Katchanov, C. Harms, K. Gertz, L. Hauck, C. Waeber, L. Hirt, J. Priller, R. von Harsdorf, W. Bruck, H. Hortnagl, U. Dirnagl, P.G. Bhide, and M. Endres Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death J. Neurosci. 21 2001 5045 5053
20. S.M. Knoblach, M. Nikolaeva, X. Huang, L. Fan, S. Krajewski, J.C. Reed, and A.I. Faden Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome J. Neurotrauma 19 2002 1155 1170
21. L.O. Koskinen Effect of low intravenous doses of TRH, acid-TRH and cyclo(His-Pro) on cerebral and peripheral blood flows Br. J. Pharmacol. 87 1986 509 519
22. I. Loubinoux, A. Volk, J. Borredon, S. Guirimand, B. Tiffon, J. Seylaz, and P. Meric Spreading of vasogenic edema and cytotoxic edema assessed by quantitative diffusion and T2 magnetic resonance imaging Stroke 28 1997 419 426 (discussion 426-417)
23. V.A. Movsesyan, B.A. Stoica, and A.I. Faden MGLuR5 activation reduces beta-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor J. Neurochem. 89 2004 1528 1536
24. A.G. Mukhin, S.A. Ivanova, S.M. Knoblach, and A.I. Faden New in vitro model of traumatic neuronal injury: evaluation of secondary injury and glutamate receptor-mediated neurotoxicity J. Neurotrauma 14 1997 651 663
25. J.E. Natale, F. Ahmed, I. Cernak, B. Stoica, and A.I. Faden Gene expression profile changes are commonly modulated across models and species after traumatic brain injury J. Neurotrauma 20 2003 907 927
26. L.H. Pitts, A. Ross, G.A. Chase, and A.I. Faden Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries J. Neurotrauma 12 1995 235 243
27. K.R. Prakash, Y. Tang, A.P. Kozikowski, J.L. Flippen-Anderson, S.M. Knoblach, and A.I. Faden Synthesis and biological activity of novel neuroprotective diketopiperazines Bioorg. Med. Chem. 10 2002 3043 3048
28. C. Prasad Bioactive cyclic dipeptides Peptides 16 1995 151 164
29. M.A. Puniak, G.M. Freeman, C.A. Agresta, L. Van Newkirk, C.A. Barone, and S.K. Salzman Comparison of a serotonin antagonist, opioid antagonist, and TRH analog for the acute treatment of experimental spinal trauma J. Neurotrauma 8 1991 193 203
30. W.R. Schabitz, S. Schwab, M. Spranger, and W. Hacke Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats J. Cereb. Blood Flow Metab. 17 1997 500 506
31. D.M. Seyfried, R. Veyna, Y. Han, K. Li, N. Tang, R.L. Betts, S. Weinsheimer, M. Chopp, and J. Anagli A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats undergoing transient middle cerebral artery ischemia Brain Res. 901 2001 94 101
32. F.R. Sharp, and M. Bernaudin HIF1 and oxygen sensing in the brain Nat. Rev. Neurosci. 5 2004 437 448
33. M.C. Sun, C.R. Honey, C. Berk, N.L. Wong, and J.K. Tsui Regulation of aquaporin-4 in a traumatic brain injury model in rats J. Neurosurg. 98 2003 565 569
34. C.M. Tolias, and M.R. Bullock Critical appraisal of neuroprotection trials in head injury: what have we learned? NeuroRX 1 2004 71 79
35. J. Truettner, R. Schmidt-Kastner, R. Busto, O.F. Alonso, J.Y. Loor, W.D. Dietrich, and M.D. Ginsberg Expression of brain-derived neurotrophic factor, nerve growth factor, and heat shock protein HSP70 following fluid percussion brain injury in rats J. Neurotrauma 16 1999 471 486
36. R. Vink, and C. Van Den Heuvel Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury Expert Opin. Invest. Drugs 13 2004 1263 1274
37. J.H. Weishaupt, L. Kussmaul, P. Grotsch, A. Heckel, G. Rohde, H. Romig, M. Bahr, and F. Gillardon Inhibition of CDK5 is protective in necrotic and apoptotic paradigms of neuronal cell death and prevents mitochondrial dysfunction Mol. Cell. Neurosci. 24 2003 489 502
38. A.G. Yakovlev, and A.I. Faden Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies NeuroRX 1 2004 5 16
39. M.A. Yenari Heat shock proteins and neuroprotection Adv. Exp. Med. Biol. 513 2002 281 299
40. X. Zhao, B.R. Pike, J.K. Newcomb, K.K. Wang, R.M. Posmantur, and R.L. Hayes Maitotoxin induces calpain but not caspase-3 activation and necrotic cell death in primary septo-hippocampal cultures Neurochem. Res. 24 1999 371 382